The current study aimed to further explore the relevance of ALCAM in prostate cancer cells and associated mechanisms, the potential of serum ALCAM to act as a biomarker of prostate cancer and the impact of an ALCAM-Fc chimera, containing extracellular regions of ALCAM, to influence other cell types involved in the metastatic cascade. The gene discussed is ALCAM; the disease is prostate carcinoma.